Author Correction: High-dose nusinersen for spinal muscular atrophy: a phase 3 randomized trial.
Saved in:
| Title: | Author Correction: High-dose nusinersen for spinal muscular atrophy: a phase 3 randomized trial. |
|---|---|
| Authors: | Finkel RS; St. Jude Children's Research Hospital, Memphis, TN, USA. richard.finkel@stjude.org., Crawford TO; Johns Hopkins University School of Medicine, Baltimore, MD, USA., Mercuri E; Centro clinico NeMO, Fondazione A. Policlinico Gemelli IRCCS, Rome, Italy.; Pediatric Neurology Unit, Catholic University, Rome, Italy., Sumner CJ; Johns Hopkins University School of Medicine, Baltimore, MD, USA., Garcia Romero MDM; Hospital La Paz, Madrid, Spain., Day JW; Stanford University School of Medicine, Stanford, CA, USA., Montes J; Columbia University Irving Medical Center, New York, NY, USA., Sun P; Biogen, Cambridge, MA, USA., Tichler B; Biogen, Zug, Switzerland., Paradis AD; Biogen, Cambridge, MA, USA., Boesch E; Biogen, Cambridge, MA, USA., Inra J; Biogen, Cambridge, MA, USA., Littauer R; Biogen, Cambridge, MA, USA., Sohn J; Biogen, Cambridge, MA, USA., Monine M; Biogen, Cambridge, MA, USA., Gambino G; Biogen, Maidenhead, UK., Foster R; Biogen, Maidenhead, UK., Farewell R; Biogen, Cambridge, MA, USA., Fradette S; Biogen, Cambridge, MA, USA. stephanie.fradette@biogen.com. |
| Source: | Nature medicine [Nat Med] 2026 May; Vol. 32 (5), pp. 1936. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42026265 AccessLevel: 2 PubTypeId: unknown PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Author Correction: High-dose nusinersen for spinal muscular atrophy: a phase 3 randomized trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Finkel+RS%22">Finkel RS</searchLink>; St. Jude Children's Research Hospital, Memphis, TN, USA. richard.finkel@stjude.org.<br /><searchLink fieldCode="AU" term="%22Crawford+TO%22">Crawford TO</searchLink>; Johns Hopkins University School of Medicine, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Mercuri+E%22">Mercuri E</searchLink>; Centro clinico NeMO, Fondazione A. Policlinico Gemelli IRCCS, Rome, Italy.; Pediatric Neurology Unit, Catholic University, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Sumner+CJ%22">Sumner CJ</searchLink>; Johns Hopkins University School of Medicine, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Garcia+Romero+MDM%22">Garcia Romero MDM</searchLink>; Hospital La Paz, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Day+JW%22">Day JW</searchLink>; Stanford University School of Medicine, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Montes+J%22">Montes J</searchLink>; Columbia University Irving Medical Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Sun+P%22">Sun P</searchLink>; Biogen, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Tichler+B%22">Tichler B</searchLink>; Biogen, Zug, Switzerland.<br /><searchLink fieldCode="AU" term="%22Paradis+AD%22">Paradis AD</searchLink>; Biogen, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Boesch+E%22">Boesch E</searchLink>; Biogen, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Inra+J%22">Inra J</searchLink>; Biogen, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Littauer+R%22">Littauer R</searchLink>; Biogen, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Sohn+J%22">Sohn J</searchLink>; Biogen, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Monine+M%22">Monine M</searchLink>; Biogen, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Gambino+G%22">Gambino G</searchLink>; Biogen, Maidenhead, UK.<br /><searchLink fieldCode="AU" term="%22Foster+R%22">Foster R</searchLink>; Biogen, Maidenhead, UK.<br /><searchLink fieldCode="AU" term="%22Farewell+R%22">Farewell R</searchLink>; Biogen, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Fradette+S%22">Fradette S</searchLink>; Biogen, Cambridge, MA, USA. stephanie.fradette@biogen.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229502015%22">Nature medicine</searchLink> [Nat Med] 2026 May; Vol. 32 (5), pp. 1936. – Name: TypePub Label: Publication Type Group: TypPub Data: Published Erratum – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Company%22">Nature Publishing Company </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9502015 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1546-170X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210788956%22">10788956 </searchLink><i>NLM ISO Abbreviation: </i>Nat Med <i>Subsets: </i>MEDLINE; In Process |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42026265 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41591-026-04415-5 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1936 Titles: – TitleFull: Author Correction: High-dose nusinersen for spinal muscular atrophy: a phase 3 randomized trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Finkel RS – PersonEntity: Name: NameFull: Crawford TO – PersonEntity: Name: NameFull: Mercuri E – PersonEntity: Name: NameFull: Sumner CJ – PersonEntity: Name: NameFull: Garcia Romero MDM – PersonEntity: Name: NameFull: Day JW – PersonEntity: Name: NameFull: Montes J – PersonEntity: Name: NameFull: Sun P – PersonEntity: Name: NameFull: Tichler B – PersonEntity: Name: NameFull: Paradis AD – PersonEntity: Name: NameFull: Boesch E – PersonEntity: Name: NameFull: Inra J – PersonEntity: Name: NameFull: Littauer R – PersonEntity: Name: NameFull: Sohn J – PersonEntity: Name: NameFull: Monine M – PersonEntity: Name: NameFull: Gambino G – PersonEntity: Name: NameFull: Foster R – PersonEntity: Name: NameFull: Farewell R – PersonEntity: Name: NameFull: Fradette S IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2026 May Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1546-170X Numbering: – Type: volume Value: 32 – Type: issue Value: 5 Titles: – TitleFull: Nature medicine Type: main |
| ResultId | 1 |